{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:53:58Z","timestamp":1791629638868,"version":"4.3.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":1525,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/bja\/aet154","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T22:34:13Z","timestamp":1368138853000},"page":"549-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Antifibrinolytic agents in current anaesthetic practice"],"prefix":"10.1016","volume":"111","author":[{"given":"E","family":"Ortmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Besser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aet154_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCOUTCOMES.109.858811","article-title":"Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes","volume":"2","author":"Mehta","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1093\/bja\/aet154_bib2","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","author":"Murphy","year":"2007","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet154_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/EJA.0b013e32832c5280","article-title":"Perioperative blood conservation","volume":"26","author":"Cardone","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aet154_bib4","series-title":"Postgraduate Haematology","article-title":"Normal haemostasis","author":"Gomez","year":"2011"},{"key":"10.1093\/bja\/aet154_bib5","series-title":"Hemostasis and Thrombosis : Basic Principles and Clinical Practice","article-title":"Therapy with Antifibrinolytic Agents","author":"Hedner","year":"2001"},{"issue":"Suppl. 1","key":"10.1093\/bja\/aet154_bib6","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/00005344-199600001-00011","article-title":"Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?","volume":"27","author":"Dietrich","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1093\/bja\/aet154_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0003-4975(93)90149-C","article-title":"Aprotinin in perspective","volume":"55","author":"Westaby","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet154_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/jcan.2001.26539","article-title":"The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery","volume":"15","author":"Turkoz","year":"2001","journal-title":"J Cardiothorac Anesth"},{"key":"10.1093\/bja\/aet154_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0022-5223(03)00946-2","article-title":"Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin","volume":"126","author":"Greilich","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet154_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/FJC.0b013e318168400a","article-title":"Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass","volume":"51","author":"Dorman","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1093\/bja\/aet154_bib11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-5223(95)70027-7","article-title":"Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans","volume":"110","author":"Hill","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet154_bib12","doi-asserted-by":"crossref","first-page":"I265","DOI":"10.1161\/hc37t1.094781","article-title":"Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid","volume":"104","author":"Greilich","year":"2001","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet154_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1213\/ANE.0b013e3181e0549f","article-title":"Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass","volume":"111","author":"Homi","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1051\/ject\/200941079","article-title":"Anti-inflammatory effect of aprotinin: a meta-analysis","volume":"41","author":"Brown","year":"2009","journal-title":"J Extra Corpor Technol"},{"key":"10.1093\/bja\/aet154_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(87)91190-1","article-title":"Effect of aprotinin on need for blood transfusion after repeat open-heart surgery","volume":"2","author":"Royston","year":"1987","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet154_bib16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.athoracsur.2007.05.015","article-title":"Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery","volume":"84","author":"Dietrich","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet154_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jtcvs.2004.03.041","article-title":"Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials","volume":"128","author":"Sedrakyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet154_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet154_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet154_bib20","first-page":"CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"1","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib21","series-title":"Health Canada decision on Trasylol (aprotinin)","year":"2012"},{"key":"10.1093\/bja\/aet154_bib22","unstructured":"Bayer_Inc._Canada, 2011, Health Canada Endorsed Important Safety Information on TRASYLOL\u00ae (aprotinin)."},{"key":"10.1093\/bja\/aet154_bib23","unstructured":"European Medicines Agency, European Medicines Agency recommends lifting suspension of aprotinin: review finds that benefits of all antifibrinolytic medicines outweigh risks in restricted range of indications, Available from http:\/\/www.ema.europa.eu\/ema\/pages\/news_and_events\/news\/2012\/02\/news_detail_001447.jsp (accessed 7 April 2012)."},{"key":"10.1093\/bja\/aet154_bib24","first-page":"CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"4","author":"Henry","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib25","unstructured":"S Okamoto, Her Majesty's Stationery Office, British Patent Specification No. 770,693, 1957, London."},{"key":"10.1093\/bja\/aet154_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","article-title":"Clinical application of inhibitors of fibrinolysis","volume":"29","author":"Verstraete","year":"1985","journal-title":"Drugs"},{"key":"10.1093\/bja\/aet154_bib27","series-title":"Hemostasis and Thrombosis, Principles and Practice","author":"Coleman","year":"2000"},{"key":"10.1093\/bja\/aet154_bib28","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.CIR.84.5.2063","article-title":"Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery","volume":"84","author":"Horrow","year":"1991","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet154_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1213\/00000539-199607000-00005","article-title":"Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery","volume":"83","author":"Shore-Lesserson","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5223(95)70118-4","article-title":"Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial","volume":"110","author":"Karski","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet154_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000542-199502000-00009","article-title":"The dose-response relationship of tranexamic acid","volume":"82","author":"Horrow","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib32","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00000542-199906000-00019","article-title":"Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery","volume":"90","author":"Butterworth","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1213\/ane.0b013e318184bc20","article-title":"The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients","volume":"107","author":"Martin","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1213\/ANE.0b013e3181c92b23","article-title":"High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients","volume":"110","author":"Murkin","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib35","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1213\/ane.0b013e3181a04d69","article-title":"Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia","volume":"108","author":"Mohseni","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1213\/01.ane.0000250436.17786.72","article-title":"Death after an inadvertent intrathecal injection of tranexamic acid","volume":"104","author":"Garcha","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000542-200301000-00042","article-title":"Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid","volume":"98","author":"Yeh","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.jvca.2010.10.007","article-title":"Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid","volume":"25","author":"Martin","year":"2011","journal-title":"J Cardiothorac Anesth"},{"key":"10.1093\/bja\/aet154_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejcts.2008.09.038","article-title":"The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery","volume":"35","author":"Breuer","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aet154_bib40","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.ejcts.2010.12.030","article-title":"High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement","volume":"39","author":"Keyl","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aet154_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.athoracsur.2011.07.085","article-title":"High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass","volume":"93","author":"Kalavrouziotis","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet154_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12630-011-9618-z","article-title":"Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors","volume":"59","author":"Manji","year":"2012","journal-title":"Can J Anaesth"},{"key":"10.1093\/bja\/aet154_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.athoracsur.2010.06.083","article-title":"Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients","volume":"90","author":"Berman","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet154_bib44","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI63375","article-title":"Tranexamic acid concentrations associated with human seizures inhibit glycine receptors","volume":"122","author":"Lecker","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aet154_bib45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1537-2995.1976.16577039303.x","article-title":"Fibrinolysis and disseminated intravascular coagulation in open heart surgery","volume":"16","author":"Umlas","year":"1976","journal-title":"Transfusion"},{"key":"10.1093\/bja\/aet154_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0888-6296(89)92642-2","article-title":"Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery","volume":"3","author":"Tanaka","year":"1989","journal-title":"J Cardiothorac Anesth"},{"key":"10.1093\/bja\/aet154_bib47","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1161\/CIRCULATIONAHA.106.671222","article-title":"Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery","volume":"115","author":"Brown","year":"2007","journal-title":"Circulation"},{"key":"10.1093\/bja\/aet154_bib48","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ejcts.2009.11.055","article-title":"Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies","volume":"37","author":"Ngaage","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aet154_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1213\/ANE.0b013e3181c0ea6d","article-title":"The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery","volume":"110","author":"Karkouti","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib50","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/cc9216","article-title":"Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis","volume":"14","author":"Sander","year":"2010","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aet154_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejcts.2008.11.038","article-title":"Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial","volume":"36","author":"Later","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aet154_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1213\/ane.0b013e3181a40b5d","article-title":"The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial","volume":"109","author":"Greilich","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jtcvs.2011.06.048","article-title":"Comparative analysis of antifibrinolytic medications in pediatric heart surgery","volume":"143","author":"Pasquali","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/bja\/aet154_bib54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00540-011-1235-z","article-title":"Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial","volume":"25","author":"Shimizu","year":"2011","journal-title":"J Anesth"},{"key":"10.1093\/bja\/aet154_bib55","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ejcts.2010.09.041","article-title":"Tranexamic acid versus varepsilon-aminocaproic acid: efficacy and safety in paediatric cardiac surgery","volume":"39","author":"Martin","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aet154_bib56","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/bja\/aer267","article-title":"Switch from aprotinin to epsilon-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery","volume":"107","author":"Martin","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet154_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/bja\/aes430","article-title":"Replacement of aprotinin by {varepsilon}-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome","volume":"110","author":"Martin","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet154_bib58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00000542-200501000-00028","article-title":"Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials","volume":"102","author":"Cheng","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.imi.0000242160.21278.b7","article-title":"Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers","volume":"1","author":"Kon","year":"2006","journal-title":"Innovations (Phila)"},{"key":"10.1093\/bja\/aet154_bib60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/erc.11.51","article-title":"Hypercoagulable state after off-pump coronary artery bypass grafting: evidence, mechanisms and implications","volume":"9","author":"Raja","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1093\/bja\/aet154_bib61","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.athoracsur.2008.04.047","article-title":"Is aprotinin safe to use in a cohort at increased risk for thrombotic events: results from a randomized, prospective trial in off-pump coronary artery bypass","volume":"86","author":"Grant","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/bja\/aet154_bib62","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1213\/ANE.0b013e3181b81068","article-title":"A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery","volume":"109","author":"Desai","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.jvca.2010.08.012","article-title":"Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis","volume":"25","author":"Adler Ma","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1093\/bja\/aet154_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1213\/ANE.0b013e3182264a11","article-title":"Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study","volume":"115","author":"Wang","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aet154_bib66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/ALN.0b013e31823497dd","article-title":"First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study","volume":"115","author":"Gorlinger","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.injury.2006.10.003","article-title":"Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients","volume":"38","author":"Maegele","year":"2007","journal-title":"Injury"},{"key":"10.1093\/bja\/aet154_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","article-title":"Early coagulopathy predicts mortality in trauma","volume":"55","author":"MacLeod","year":"2003","journal-title":"J Trauma"},{"key":"10.1093\/bja\/aet154_bib69","first-page":"748","article-title":"The coagulopathy of trauma: a review of mechanisms","volume":"65","author":"Hess","year":"2008","journal-title":"J Trauma"},{"key":"10.1093\/bja\/aet154_bib70","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/bja\/aen083","article-title":"Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients","volume":"100","author":"Levrat","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet154_bib71","first-page":"125","article-title":"Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry","volume":"67","author":"Schochl","year":"2009","journal-title":"J Trauma"},{"key":"10.1093\/bja\/aet154_bib72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/bja\/aer158","article-title":"Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the \u2018Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study\u2019","volume":"107","author":"Tauber","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet154_bib73","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1213\/ANE.0b013e31822e183f","article-title":"Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma","volume":"113","author":"Theusinger","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-6576.2009.02132.x","article-title":"Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy","volume":"54","author":"Brenni","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1093\/bja\/aet154_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet154_bib76","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet154_bib77","first-page":"CD004896","article-title":"Antifibrinolytic drugs for acute traumatic injury","volume":"1","author":"Roberts","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib78","doi-asserted-by":"crossref","first-page":"d3795","DOI":"10.1136\/bmj.d3795","article-title":"Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study)","volume":"343","year":"2011","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aet154_bib79","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc8943","article-title":"Management of bleeding following major trauma: an updated European guideline","volume":"14","author":"Rossaint","year":"2010","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aet154_bib80","first-page":"CD006883","article-title":"Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children","volume":"3","author":"Tzortzopoulou","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib81","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1213\/ane.0b013e3181831e44","article-title":"Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery","volume":"107","author":"Wong","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib82","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1097\/BRS.0b013e31823d009b","article-title":"Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?","volume":"37","author":"Dhawale","year":"2012","journal-title":"Spine"},{"key":"10.1093\/bja\/aet154_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2482-10-13","article-title":"A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery","volume":"10","author":"Verma","year":"2010","journal-title":"BMC Surg"},{"key":"10.1093\/bja\/aet154_bib84","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00000542-200611000-00026","article-title":"Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?","volume":"105","author":"Zufferey","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aet154_bib85","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.thromres.2008.09.015","article-title":"Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials","volume":"123","author":"Kagoma","year":"2009","journal-title":"Thromb Res"},{"key":"10.1093\/bja\/aet154_bib86","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2001.03781.x","article-title":"Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit","volume":"96","author":"Hu","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/bja\/aet154_bib87","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/bja\/aeq022","article-title":"Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation","volume":"104","author":"Roullet","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aet154_bib88","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(00)02111-5","article-title":"Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group","volume":"355","author":"Porte","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet154_bib89","first-page":"29","article-title":"Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation","volume":"91","author":"Dalmau","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet154_bib90","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.20075","article-title":"The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study","volume":"10","author":"Dalmau","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1093\/bja\/aet154_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","article-title":"Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis","volume":"7","author":"Molenaar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1093\/bja\/aet154_bib92","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/TP.0b013e31821ab9f8","article-title":"Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival","volume":"91","author":"Massicotte","year":"2011","journal-title":"Transplantation"},{"key":"10.1093\/bja\/aet154_bib93","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1537-2995.2006.00770.x","article-title":"Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation","volume":"46","author":"Ickx","year":"2006","journal-title":"Transfusion"},{"key":"10.1093\/bja\/aet154_bib94","first-page":"CD009052","article-title":"Methods to decrease blood loss and transfusion requirements for liver transplantation","volume":"12","author":"Gurusamy","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib95","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/lt.21768","article-title":"Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients","volume":"15","author":"Warnaar","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1093\/bja\/aet154_bib96","first-page":"19","article-title":"The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products","volume":"15","author":"Trzebicki","year":"2010","journal-title":"Ann Transplant"},{"key":"10.1093\/bja\/aet154_bib97","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1055\/s-0037-1617084","article-title":"Coagulation management during liver transplantation","volume":"26","author":"Gorlinger","year":"2006","journal-title":"Hamostaseologie"},{"key":"10.1093\/bja\/aet154_bib98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.sla.0000197561.70972.73","article-title":"Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a \u201cblood transfusion\u201d-free hepatectomy","volume":"243","author":"Wu","year":"2006","journal-title":"Ann Surg"},{"key":"10.1093\/bja\/aet154_bib99","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","article-title":"Maternal mortality: who, when, where, and why","volume":"368","author":"Ronsmans","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1093\/bja\/aet154_bib100","first-page":"1","article-title":"Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"10.1093\/bja\/aet154_bib101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0301-2115(03)00287-2","article-title":"Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi-center, randomized trial","volume":"112","author":"Gai","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1093\/bja\/aet154_bib102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2393-9-29","article-title":"Anti-fibrinolytic agents in post partum haemorrhage: a systematic review","volume":"9","author":"Ferrer","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1093\/bja\/aet154_bib103","first-page":"227","article-title":"Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomised case controlled prospective study","volume":"57","author":"Gohel","year":"2007","journal-title":"J Obstet Gynaecol India"},{"key":"10.1093\/bja\/aet154_bib104","first-page":"590","article-title":"Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loss: a randomized, comparative, multicenter trial","volume":"36","author":"Yang","year":"2001","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1093\/bja\/aet154_bib105","first-page":"CD007872","article-title":"Tranexamic acid for preventing postpartum haemorrhage","volume":"7","author":"Novikova","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib106","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Critical Care"},{"key":"10.1093\/bja\/aet154_bib107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0030-1268238","article-title":"Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study","volume":"28","author":"Gungorduk","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1093\/bja\/aet154_bib108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"key":"10.1093\/bja\/aet154_bib109","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3171\/jns.1987.67.3.0329","article-title":"The risk of rebleeding from ruptured intracranial aneurysms","volume":"67","author":"Rosenorn","year":"1987","journal-title":"J Neurosurg"},{"key":"10.1093\/bja\/aet154_bib110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12028-011-9581-0","article-title":"Rebleeding after aneurysmal subarachnoid hemorrhage","volume":"15","author":"Starke","year":"2011","journal-title":"Neurocritical Care"},{"key":"10.1093\/bja\/aet154_bib111","first-page":"CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"2","author":"Roos","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet154_bib112","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"10.1093\/bja\/aet154_bib113","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1093\/bja\/aet154_bib114","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/STROKEAHA.107.506097","article-title":"Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage","volume":"39","author":"Starke","year":"2008","journal-title":"Stroke"},{"key":"10.1093\/bja\/aet154_bib115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1227\/NEU.0b013e3181ebaa36","article-title":"Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus","volume":"67","author":"Harrigan","year":"2010","journal-title":"Neurosurgery"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217323474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217323474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/111\/4\/549\/659616\/aet154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:38:10Z","timestamp":1757788690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217323474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0007091217323474"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aet154","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifibrinolytic agents in current anaesthetic practice","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aet154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}